FertiQoL is the first internationally validated instrument to measure quality of life in individuals experiencing fertility problems. Created in partnership with The European Society of Human Reproduction and Embryology (ESHRE) and the American Society of Reproductive Medicine (ASRM) with support from leading pharmaceutical company, Merck-Serono S.A..
Best practice in fertility care involves a comprehensive approach to the ordeal of infertility. FertiQoL helps achieve this goal by providing an excellent means of integrating quality of life issues in clinical care and research endeavours. We invite clinicians and researchers to use FertiQoL in upcoming projects, whether these are epidemiological surveys, cross-cultural studies, clinical trials or psychosocial intervention projects. We hope that together we can further the aim of improving quality of life for people with fertility problems.
FertiQoL assesses the influences of fertility problems in diverse life areas, for example, on general health, self-perceptions, emotions, partnership, family and social relationships, work life and future life plans. Additionally the optional FertiQoL Treatment module assesses the environment and tolerability of fertility treatment.
FertiQoL is the disease-specific instrument most commonly used for measuring quality of life in people with fertility problems, and has been translated into more than 50 languages.